Dr. Lal Pathlabs Ltd.

NSE: LALPATHLAB | BSE: 539524 | ISIN: INE600L01024 | Industry: Healthcare Services
| Mid-range Performer
2768.9000 19.50 (0.71%)
NSE Jun 27, 2025 15:31 PM
Volume: 201.7K
 

logo
Dr. Lal Pathlabs Ltd.
26 Apr 2025, 12:00AM
2768.90
0.71%
Emkay
DLPL reported a steady Q4, with EBITDA beating street/our estimates by 6% and adj PAT improving 34% on YoY basis. Strong performance in core markets (Delhi NCR), buoyed by network expansion, offset the persistent muted performance of Suburban (mid-single digit revenue growth).
Dr. Lal Pathlabs Ltd. has an average target of 2992.60 from 5 brokers.
More from Dr. Lal Pathlabs Ltd.
Recommended